Search reports.
US Esoteric Testing Market Size, Industry Trends Report 2031
Get free sample report Request for Customiztion Buy Now

US Esoteric Testing Market Size, Industry Trends Report 2031

Segments - US Esoteric Testing Market by Types (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetic Testing, Toxicology Testing, Immunology Testing, Neurology Testing, and Others), and Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Mass Spectrometry, Real-time PCR, Flow Cytometry, Radioimmunoassay, and Others), Country (US) - US Industry Analysis, Growth, Share, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1816 | 4.6 Rating | 81 Reviews | 178 Pages | Format : PDF Excel PPT

Report Description


US Esoteric Testing Market Outlook 2031:

The US esoteric testing market size was valued at USD 7.49 Billion in 2022 and is projected to reach USD 13.43 Billion by 2031, expanding at a CAGR of 6.7% during the forecast period 2023 - 2031. The growth of the market is attributed to increasing awareness regarding early diagnosis of rare diseases. Moreover, ongoing technological advancements is driving the market growth.

Esoteric testing refers to the analysis of molecules that are not performed in clinical laboratories. These tests require precise instruments and are carried out by specialized personnel. According to the American Cancer Society, around 23% of cancer patients are diagnosed with the rarer form of cancers. These tests are outsourced owing to requirement of sophisticated instruments.

Esoteric Testing Market Outlook

  • Growing prevalence of rare genetic conditions is driving the market growth.
  • Rapid rise in the public-private investments for research funding & increasing number of grants to develop innovative laboratory testing procedures are the key factors driving the growth of the market
  • Rising demand for precise diagnosis & treatment and advancements in genomics and proteomics are expected to spur the growth of the market
  • Strict regulatory framework can hinder the market growth
  • Lack of awareness about the tests can restrict the market expansion in the projected timeline.
  • The COVID-19 pandemic has increased the awareness about the infectious disease and encouraged people for early diagnosis, positively influencing the market growth.
  • Increasing use of molecular diagnostics and genomics & proteomics technologies are some of the factors that can boost the market growth during the forecast period.

Scope of Esoteric Testing Market Report

The report on the US esoteric testing market includes an assessment of the market, trends, segments and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

US Esoteric Testing Market- Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Types (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetic Testing, Toxicology Testing, Immunology Testing, Neurology Testing and Others) and Technology (Chemiluminescence Immunoassay, Enzyme-linked Immunosorbent Assay, Mass Spectrometry, Real-time PCR, Flow Cytometry, Radioimmunoassay, Others)

Geography

The US

Report Coverage

Market Analysis and Size, Market Segment, Competitive Landscape, Driving  Factors, and Trends, and Revenue Forecast.

Key Players Covered in the Report

Laboratory corporation of America, Opko health company, Mayo medical laboratories, myriad genetics, Genomic heal, Miraca holdings Inc, Fulgent genetics Inc. and Invitae.

Global High Capacity Power Bank Market Segment Insights

Infectious disease testing market account a large market share

Based on types, the market is divided into infectious diseases testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and others. The infectious disease testing segment is anticipated to account for a large market shares due to increasing demand for diagnosis of diseases caused by pathogenic organisms such as viruses, bacteria, fungi, or parasites.

Infectious diseases such as influenza, HIV, hepatitis, malaria, and others can be detected easily.  The infectious disease testing segment is expected to expand at a CAGR of 8% in the US during the forecast period.

The oncology testing segment is expected to grow at a healthy rate during the forecast period. Increasing prevalence of cancer is driving the growth of the market segment. The improvement in the insurance plans and increasing government expenditure on healthcare infrastructure are spurring the growth of the oncology testing equipment.

Esoteric Testing Market Types

Mass spectrometry to dominate the market

On the basis of technology, the market is segmented into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, flow cytometry, radioimmunoassay, others.  The mass spectrometry market size in the US was around USD 1.1 Billion in the year 2020 and is expected to propel at rapid pace during forecast period, 2021-2028.

Increasing demand for cost-effective testing is driving the segment growth. Conversely, the real-time PCR segment is expected to grow at a healthy rate in the coming years.

Esoteric Testing Market Technology

Segments

Types

  • Infectious Diseases Testing
  • Endocrinology Testing
  • Oncology Testing
  • Genetic Testing
  • Toxicology Testing
  • Immunology Testing
  • Neurology Testing
  • Others

Technology

  • Chemiluminescence Immunoassay
  • Enzyme-Linked Immunosorbent Assay
  • Mass Spectrometry
  • Real-Time PC
  • Flow Cytometry
  • Radioimmunoassay
  • Other Technologies

Key players

Competitive Landscape

The major players covered in US esoteric testing market are laboratory corporation of America, Opko health company, Mayo medical laboratories, myriad genetics, Genomic heal, Miraca holdings Inc, Fulgent genetics Inc. and Invitae.

Companies are engaging in acquisitions and mergers, research & developments, and product development to expand their market share.

Esoteric Testing Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Esoteric Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Esoteric Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Esoteric Testing Market - Supply Chain
  4.5. Global Esoteric Testing Market Forecast
     4.5.1. Esoteric Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Esoteric Testing Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Esoteric Testing Market Absolute $ Opportunity
5. Global Esoteric Testing Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Esoteric Testing Market Size and Volume Forecast by Types
     5.3.1. Infectious Diseases Testing
     5.3.2. Endocrinology Testing
     5.3.3. Oncology Testing
     5.3.4. Genetic Testing
     5.3.5. Toxicology Testing
     5.3.6. Immunology Testing
     5.3.7. Neurology Testing
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Esoteric Testing Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Esoteric Testing Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Esoteric Testing Demand Share Forecast, 2019-2026
7. North America Esoteric Testing Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Esoteric Testing Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Esoteric Testing Market Size and Volume Forecast by Types
     7.4.1. Infectious Diseases Testing
     7.4.2. Endocrinology Testing
     7.4.3. Oncology Testing
     7.4.4. Genetic Testing
     7.4.5. Toxicology Testing
     7.4.6. Immunology Testing
     7.4.7. Neurology Testing
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Esoteric Testing Demand Share Forecast, 2019-2026
8. Latin America Esoteric Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Esoteric Testing Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Esoteric Testing Market Size and Volume Forecast by Types
     8.4.1. Infectious Diseases Testing
     8.4.2. Endocrinology Testing
     8.4.3. Oncology Testing
     8.4.4. Genetic Testing
     8.4.5. Toxicology Testing
     8.4.6. Immunology Testing
     8.4.7. Neurology Testing
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Esoteric Testing Demand Share Forecast, 2019-2026
9. Europe Esoteric Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Esoteric Testing Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Esoteric Testing Market Size and Volume Forecast by Types
     9.4.1. Infectious Diseases Testing
     9.4.2. Endocrinology Testing
     9.4.3. Oncology Testing
     9.4.4. Genetic Testing
     9.4.5. Toxicology Testing
     9.4.6. Immunology Testing
     9.4.7. Neurology Testing
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Esoteric Testing Demand Share Forecast, 2019-2026
10. Asia Pacific Esoteric Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Esoteric Testing Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Esoteric Testing Market Size and Volume Forecast by Types
     10.4.1. Infectious Diseases Testing
     10.4.2. Endocrinology Testing
     10.4.3. Oncology Testing
     10.4.4. Genetic Testing
     10.4.5. Toxicology Testing
     10.4.6. Immunology Testing
     10.4.7. Neurology Testing
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Esoteric Testing Demand Share Forecast, 2019-2026
11. Middle East & Africa Esoteric Testing Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Esoteric Testing Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Esoteric Testing Market Size and Volume Forecast by Types
     11.4.1. Infectious Diseases Testing
     11.4.2. Endocrinology Testing
     11.4.3. Oncology Testing
     11.4.4. Genetic Testing
     11.4.5. Toxicology Testing
     11.4.6. Immunology Testing
     11.4.7. Neurology Testing
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Esoteric Testing Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Esoteric Testing Market: Market Share Analysis
  12.2. Esoteric Testing Distributors and Customers
  12.3. Esoteric Testing Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Laboratory Corporation of America
     12.4.2. Opko Health Company
     12.4.3. Mayo Medical Laboratories
     12.4.4. Myriad Genetics
     12.4.5. Genomic Heal
     12.4.6. Miraca Holdings Inc
     12.4.7. Fulgent Genetics Inc

Methodology

Our Clients

Microsoft
Deloitte
General Electric
Siemens Healthcare
Honda Motor Co. Ltd.
Pfizer
The John Holland Group
Nestle SA